Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-070358
Filing Date
2023-06-12
Accepted
2023-06-12 16:15:51
Documents
1
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318463-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2318463-3_4seq1.xml 4 7035
  Complete submission text file 0001104659-23-070358.txt   8453
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 231008257

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations